Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 26.53M P/E - EPS this Y 38.80% Ern Qtrly Grth -
Income -39.7M Forward P/E -0.69 EPS next Y -7.30% 50D Avg Chg -45.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -34.00%
Dividend N/A Price/Book 0.77 EPS next 5Y - 52W High Chg -81.00%
Recommedations 1.60 Quick Ratio 40.12 Shares Outstanding 59.11M 52W Low Chg 51.00%
Insider Own 0.24% ROA -22.06% Shares Float 41.05M Beta 1.27
Inst Own 104.58% ROE -51.87% Shares Shorted/Prior 6.26M/6.40M Price 1.09
Gross Margin - Profit Margin - Avg. Volume 1,770,519 Target Price 8.00
Oper. Margin - Earnings Date Aug 6 Volume 342,146 Change -7.63%
About Elevation Oncology, Inc.

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a clinically validated molecular target. Its EO-3021 selectively delivers a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Elevation Oncology, Inc. has a license agreement with CSPC Megalith Biopharmaceutical Co., Ltd. to develop and commercialize EO-3021. The company was formerly known as 14ner Oncology, Inc. and changed its name to Elevation Oncology, Inc. in February 2020. The company was incorporated in 2019 and is based in Boston, Massachusetts.

Elevation Oncology, Inc. News
11/06/24 Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements
10/10/24 What Makes Elevation Oncology (ELEV) a New Strong Buy Stock
10/09/24 Empery Asset Management's Strategic Acquisition in Elevation Oncology
09/23/24 Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
09/03/24 Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/07/24 Elevation Oncology reports data from Phase I trial of EO-3021 for solid tumours
08/06/24 Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements
08/06/24 Elevation Oncology Announces Promising Initial Data from Phase 1 Clinical Trial Evaluating EO-3021 in Patients with Advanced Unresectable or Metastatic Solid Tumors Likely to Express Claudin 18.2
06/27/24 Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer
05/27/24 7 Top Stocks to Buy for Under $10: May 2024
05/07/24 Elevation Oncology to Present at the Citizens JMP Life Sciences Conference
05/02/24 Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
04/11/24 7 Top Stocks Under $7
04/08/24 Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
03/07/24 Elevation Oncology Inc (ELEV) Reports Financial Results for Q4 and Full Year 2023
03/06/24 Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
03/05/24 Trim the Fat: 3 Overbought Stocks Poised for a Pullback
03/05/24 Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
03/04/24 Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors
02/28/24 Elevation Oncology to Participate in Upcoming Investor Conferences
ELEV Chatroom

User Image RamenLives Posted - 21 hours ago

$ELEV You are my Obi-Wan... only you can save my year with a huge return....LFG $10!

User Image The_Bear_Necessities Posted - 22 hours ago

$ELEV

User Image viking1111 Posted - 1 day ago

$ELEV she's going to test the 50 ma again.

User Image Liberty2018 Posted - 1 day ago

$ELEV

User Image The_Bear_Necessities Posted - 3 days ago

$ELEV

User Image viking1111 Posted - 5 days ago

$ELEV The information at nasdaq.com shows elev at 81% insts. Hudson bay a known penny short inst has covered over 1 mil shares per this site if they were short. Either way they have over a mil less shares involved here. They still have 1.3 mil shares. Morgan Stanley sold over 300k, Palo Alto over 500k, insts increased positions 21.3 mil and decreased positions 22.8 mil. Braidwell Lp sold over 2 million. For the last 4 months short int on the bi monthly report has been approx 6 mil. Has not increased from that over the last several months. We'll see what the next report shows.

User Image Anchove Posted - 6 days ago

$ELEV It’s starting to feel like this is being heavily manipulated to shake people out. Strong hold.

User Image flashmem Posted - 6 days ago

$ELEV Looks like .40’s incoming. Nothing to prevent shorts from pressing this harder until year end.

User Image The_Bear_Necessities Posted - 6 days ago

$ELEV https://www.gurufocus.com/news/2606064/orbimed-advisors-llc-increases-stake-in-elevation-oncology-inc

User Image viking1111 Posted - 6 days ago

$ELEV hardly anyone here on the retail side of things but I'm starting to add more right here at .5801, now have 25k.

User Image ownooTwits Posted - 1 week ago

$ELEV hope this doesn't go to .5 again

User Image viking1111 Posted - 1 week ago

$ELEV our daily share dumper is making it awfully easy for the 6 mil short share insts to cover near bottom.

User Image Capitulation_0 Posted - 1 week ago

$ELEV need to break .70

User Image ATCI Posted - 1 week ago

$ELEV nice

User Image lealbinagor98 Posted - 1 week ago

$AKTS The good news is coming soon, let's be patient $CHRS $ELEV

User Image RamenLives Posted - 1 week ago

$ELEV slow steady gains till 2025!

User Image Bionco Posted - 1 week ago

$ELEV woa surprising close!

User Image The_Bear_Necessities Posted - 1 week ago

$ELEV https://www.gurufocus.com/news/2587439/goldman-sachs-group-incs-strategic-acquisition-in-elevation-oncology-inc

User Image Biotech2424 Posted - 1 week ago

$CHRS Chart is looking beautiful $SMMT $ELEV $MNPR

User Image Foramen_canal Posted - 1 week ago

$ELEV They are going to announce monotherapy results in first quater of 2025 we will get 5 dollars before results load every dip . most of the float holding by strong bio pharma institutional investor most notably Tang capital and others .

User Image Bionco Posted - 1 week ago

$ELEV I won't flip for pennies here and will hold for long , at least through initial data readout( by late 2025) from the combo therapies of EO3201 with PD1 inhibitor or VEGFR2 inhibitor..

User Image Perseveranceforever Posted - 1 week ago

$ELEV TP 5 dolars?

User Image Foramen_canal Posted - 1 week ago

$ELEV They have blockbuster novel treatment . institutions loading recently .

User Image Winning_calls Posted - 1 week ago

$ELEV push πŸ€žπŸ€žπŸ‘†πŸ‘†πŸ‘†

User Image RamenLives Posted - 1 week ago

$ELEV

User Image iBoughtTheWrongTicker Posted - 1 week ago

$ELEV the fun has only begun…

User Image Novaful Posted - 1 week ago

$ELEV CURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE 83.70%. Is it correct?

User Image mcrotary Posted - 1 week ago

$ELEV good start to the week.. will hold the 25% and watch for re entry..

User Image Winning_calls Posted - 1 week ago

$ELEV keep πŸ‘ŠπŸ‘ŠπŸ‘Š

User Image Capitulation_0 Posted - 1 week ago

$ELEV I'm looking for double here in short order.

Analyst Ratings
HC Wainwright & Co. Buy Aug 7, 24
JMP Securities Market Outperform Jul 15, 24
JMP Securities Market Outperform Jun 28, 24
Piper Sandler Overweight May 31, 24
Stephens & Co. Overweight May 14, 24
Wedbush Outperform May 3, 24
HC Wainwright & Co. Buy Apr 9, 24
JMP Securities Market Outperform Mar 7, 24
Wedbush Outperform Mar 7, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
venBio Global Strategic Fund I... 10% Owner 10% Owner May 25 Sell 4.1236 702,737 2,897,806 1,905,430 05/27/22